Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Pancreas|April 10, 2024
The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer SurveillanceAleksander M Bogdanski, Anke M Onnekink, Akin Inderson, et al.
Gastroenterology|June 28, 2015
Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's DiseaseIlse Molendijk, Bert A Bonsing, Helene Roelofs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancerBoudewijn E Schaafsma, Martijn van de Giessen, Ayoub Charehbili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Pancreatic Cancer Surveillance in Carriers of a Germline <i>CDKN2A</i> Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-UpDerk C F Klatte, Bas Boekestijn, Martin N J M Wasser, et al.
Gut|May 26, 2016
Refinement of screening for familial pancreatic cancerD K Bartsch, E P Slater, A Carrato, et al.
Journal of Crohn'S & Colitis|June 15, 2019
Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal FistulasMarieke C Barnhoorn, Martin N J M Wasser, Helene Roelofs, et al.
Gastroenterology|March 8, 2023
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched AnalysisDerk C F Klatte, Bas Boekestijn, Anke M Onnekink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening StudyAdriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 30, 2012
Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combinedEveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, et al.
Cancers|October 28, 2023
<sup>89</sup>Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility StudyD G J Linders, M M Deken, M A van Dam, et al.
Pageof 10